Sacubitril/Valsartan Treatment for HFrEF Results in Removal of Prior Authorization Requirement

October 28, 2020 04:42pm

Study results demonstrate the multimillion-dollar savings achieved among patients with heart failure with reduced ejection fraction (HFrEF) following treatment initiation with sacubitril and valsartan.

What We’re Reading: Hospitals Strained; Pfizer Trial Enrollment; Variation in Virus Mitigation
Dr Faraidoon Haghdoost Explains Results of COVID-19 Migraine Triggers, Frequency Study
A Closer Look at 3 Oncology Payment Reform Projects
Dr Krishna Sundar Differentiates Between Obstructive, Central Sleep Apnea

Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge

October 28, 2020

During a session on day 1 of the Community Oncology Alliance (COA) Virtual Payer Exchange Summit on Oncology Payment Reform, a panel of experts discussed the ways COVID-19 continues to impact cancer care and payment reform.

Dr Lucio Gordan on Telehealth and New Care Initiatives in COVID-19

October 27, 2020

Lucio Gordan, MD, president and managing physician at Florida Cancer Specialists and Research Institute, discusses the impact that COVID-19 continues to have on health care delivery and payment reform initiatives as the COA Payer Exchange Summit tackles this and other issues in payment reform.

Skin Samples May Improve Earlier Diagnosis of Parkinson Disease

October 27, 2020

A skin test to detect clumping of alpha-synuclein, an abnormal protein suggested to have a central role in the pathogenesis of Parkinson disease, may assist in improving earlier detection of the condition, according to study findings.

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT2 Inhibitor Trials

October 27, 2020

Although their underlying mechanisms differ, finerenone reduces albuminuria to the same extent as SGLT2 inhibitors, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.